Publication Cover
Arab Journal of Urology
An International Journal
Volume 20, 2022 - Issue 2
6,620
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 100-104 | Received 18 Jun 2021, Accepted 02 Sep 2021, Published online: 26 Feb 2022

References

  • Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004;1:225–232.
  • Rowland DL, Patrick DL, Rothman M, et al. The psychological burden of premature ejaculation. J Urol. 2007;177:1065–1070.
  • Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816–824.
  • Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med. 2014;11:1423–1441.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5 (R)). 5th ed. Arlington (TX): American Psychiatric Association Publishing; 2013.
  • Waldinger MD. The neurobiological approach to premature ejaculation. J Urol. 2002;168:2359–2367.
  • Eltonsi TK, Tawfik TM, Rashed LA, et al. Study of the link between dopamine transporter gene polymorphisms and response to paroxetin and escitalopram in patients with lifelong premature ejaculation. Int J Impot Res. 2017;29:235–239.
  • Jern P, Ventus D. Serotonergic polymorphisms in the control of ejaculation. Mol Cell Endocrinol. 2018;467:60–65.
  • Waldinger MD, Berendsen HH, Blok BF, et al. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998;92:111–118.
  • Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6–23.
  • Porst H, Oelke M, Goldfischer ER, et al. Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinationals, randomized, placebo- controlled clinical studies. Urology. 2013;82:667–673.
  • Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med. 2006;3(Suppl 4):303–308.
  • Atalay HA, Sonkaya AR, Ozbir S, et al. Are there differences in brain morphology in patients with lifelong premature ejaculation? J Sex Med. 2019;16:992–998.
  • Asimakopoulos AD, Miano R, Finazzi Agrò E, et al. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis. J Sex Med. 2012;9:2404–2416.
  • Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int. 2008;80:162–165.
  • Abu El-Hamd M. Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia. 2018;50(5):e13005.
  • Aversa A, Francomano D, Bruzziches R, et al. Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? Int J Impot Res. 2011;23:17–23.
  • Atan A, Basar MM, Tuncel A, et al. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLAcream-only in treatment of premature ejaculation. Urology. 2006;67:388–391.
  • Mondaini N, Ponchietti R, Muir GH, et al. Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res. 2003;15:225–228.